ArticleJournal for immunotherapy of cancer2022

Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer.

Meng Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.